“oxford-bioscience-partners” Archives

Entry Author Date Location
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Who Knew? Fun Facts About Boston Innovators—the Slide Show 10/28/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Mitralign Lands $35,000,000 Series D Round 05/16/12 Boston
GloriOil Garners $20,000,000 Series C Financing Round 01/26/12 Texas
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center 01/19/12 San Diego
Rib-X Pharma Files for IPO 11/28/11 Boston
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M 08/19/11 Seattle
BrainCells Raises $1M, Moving Ahead Without CEO Schoeneck or CSO Barlow 08/03/11 San Diego
From Human Tissue Supplier to R&D Contractor to BioBank Builder, Asterand Seeks Its Future 03/16/11 Detroit Ann Arbor
CardioFocus Finds $30.6M for Atrial Fibrillation Treatment 02/25/11 Boston
Report: Oxford Bioscience Has New Fund 01/11/11 Boston
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News 11/12/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
IBM Buys Unica, A123 Spinout Raises $10M, Zynga Acquires Conduit, & More Boston-Area Deals News 08/18/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News 08/13/10 Boston
Trubion Pharmaceuticals Gets Acquired by Emergent BioSolutions for $97M Upfront 08/12/10 Seattle
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs 08/11/10 Boston
Dicerna Pharmaceuticals Garners $25,000,000 Series B Funding 08/11/10 Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
$5M Debt Deal for Dicerna Pharma 06/30/10 Boston
SmartPill Garners $7,700,000 New Funding Round 06/30/10 New York
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News 05/14/10 Boston
Doug Fambrough Reduces Role at Oxford Bioscience Partners, Becomes CEO of Portfolio Company Dicerna Pharma 05/06/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Page 1 of 4 next page »